Archives Oligomerix Awarded Phase IIB Grant From the NIH to Discover Drugs that Inhibit Alzheimer’s Disease Progression September 10, 2013 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix, Inc. to Present Multiple Posters Highlighting its Tau-Focused Technology During the Annual Alzheimer’s Association International ConferenceNext →Identification of a Tau Oligomer Structure That is Toxic to Neurons
